Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jefferies Downgrades Equitable Holdings to Hold, Lowers Price Target to $34

Jefferies analyst Suneet Kamath downgrades Equitable Holdings (NYSE:EQH) from Buy to Hold and lowers the price target from $36 to $34.

byBenzinga Newsdesk

December 9, 2022

1 minute read

Jefferies analyst Suneet Kamath downgrades Equitable Holdings (NYSE:EQH) from Buy to Hold and lowers the price target from $36 to $34.

Cowen & Co. Maintains Outperform on Chipotle Mexican Grill, Raises Price Target to $1950

By Benzinga Newsdesk

Today, 5:24 AM

Cowen & Co. analyst Andrew Charles maintains Chipotle Mexican Grill (NYSE:CMG) with a Outperform and raises the price target from $1850 to $1950.

CMG

Goldman Sachs Maintains Buy on HCA Healthcare, Raises Price Target to $279

By Benzinga Newsdesk

Today, 5:24 AM

Goldman Sachs maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $252 to $279.

HCA

AstraZeneca-Merck’s Lynparza Wins FDA Approval For Early-Stage Breast Cancer

By Vandana Singh

Today, 5:24 AM

The

AZN

American Well Q2 EPS $(0.15) Beats $(0.19) Estimate, Sales $60.20M Miss $61.70M Estimate

By Benzinga Newsdesk

Today, 5:24 AM

American Well (NYSE:AMWL) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.19) by 21.05 percent. The company reported quarterly sales of $60.20 million which missed the

AMWL

Jefferies Downgrades Equitable Holdings to Hold, Lowers Price Target to $34

Related Posts

Cowen & Co. Maintains Outperform on Chipotle Mexican Grill, Raises Price Target to $1950

Goldman Sachs Maintains Buy on HCA Healthcare, Raises Price Target to $279

AstraZeneca-Merck’s Lynparza Wins FDA Approval For Early-Stage Breast Cancer

American Well Q2 EPS $(0.15) Beats $(0.19) Estimate, Sales $60.20M Miss $61.70M Estimate